Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
CYCC - Cyclacel Pharmaceuticals Inc - Stock Price Chart
TickerCYCC [NASD]
CompanyCyclacel Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap5.66MEPS (ttm)-733.97
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y57.31%
P/S565.75EPS next 5Y-
P/B1.01EPS Q/Q99.98%
Dividend1008.40%Sales Q/Q-100.00%
Insider Own0.00%Inst Own0.43%
Insider Trans-Inst Trans-74.60%
Short Float2.50%EarningsMay 15/b
Analyst Recom3.00Target Price240.00
Avg Volume105.25K52W Range3.23 - 597.60
APIE - ActivePassive International Equity ETF - Stock Price Chart
TickerAPIE [NYSE]
CompanyActivePassive International Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Broad / Regional
Index-
TagsInternational, equity
Sector/Theme Region
Dividend1.83%Active/Passive
Total Holdings495AUM958.37M
Flows% 1M0.45%Flows% 3M1.51%
Flows% YTD3.24%Flows% 1Y
Return% 1Y17.23%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume84.41K52W Range26.18 - 34.45
SVRE - SaverOne 2014 Ltd ADR - Stock Price Chart
TickerSVRE [NASD]
CompanySaverOne 2014 Ltd ADR
CountryIsrael
IndustryScientific & Technical Instruments
Market Cap1.26MEPS (ttm)-288.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y38.93%
P/S2.80EPS next 5Y-
P/B0.12EPS Q/Q79.01%
Dividend-Sales Q/Q-1.67%
Insider Own-Inst Own9.05%
Insider Trans-Inst Trans-
Short Float-EarningsMar 21/a
Analyst Recom1.00Target Price19.50
Avg Volume1.21M52W Range1.93 - 325.43
WAI - Top KingWin Ltd - Stock Price Chart
TickerWAI [NASD]
CompanyTop KingWin Ltd
CountryChina
IndustryCapital Markets
Market Cap8.05MEPS (ttm)-0.81
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S15.48EPS next 5Y-
P/B1.08EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own1.36%Inst Own0.11%
Insider Trans0.00%Inst Trans1.82%
Short Float0.18%Earnings-
Analyst Recom-Target Price-
Avg Volume347.94K52W Range1.38 - 20.00
OVL - Overlay Shares Large Cap Equity ETF - Stock Price Chart
TickerOVL [CBOE]
CompanyOverlay Shares Large Cap Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Factor & Thematic
Index-
TagsU.S., ETFs, options, large-cap
Sector/Theme Region
Dividend3.16%Active/Passive
Total Holdings10AUM229.32M
Flows% 1M2.76%Flows% 3M1.42%
Flows% YTD30.25%Flows% 1Y
Return% 1Y13.79%Return% 3Y0.20%
Return% 5Y17.74%Return% 10Y
NAV% Expense
Avg Volume43.81K52W Range37.58 - 49.50
May-01-25 06:42AM OVL Vs. VOO: Old Dog Meets The New Dog (Seeking Alpha)
Apr-25-25 06:15AM Small Caps Vs. Large Caps: The Cycle That's About To Turn (Seeking Alpha)
Apr-19-25 02:25AM Q2 2025 Equity Market Outlook (Seeking Alpha)
Apr-04-25 09:30AM Put Spread Selling Overlays In Large-Cap Equity Portfolios (Seeking Alpha) -5.91%
Nov-05-24 01:00PM Overlay Shares to Transfer Funds to Cboe BZX Exchange (PR Newswire)
Oct-03-24 02:00PM Overlay Shares Reach 5-Year Track Record (PR Newswire)
Feb-01-22 10:51AM Overlay Shares Cross $500 Million in Assets (PR Newswire)
Jan-21-21 07:17AM Overlay Shares Launch New ETFs and Cross $300 Million in Assets (PR Newswire)
Sep-15-20 07:07AM Overlay Shares Large Cap Equity ETF Crosses $100 Million in Assets (PR Newswire)
Jul-09-20 07:07AM Overlay Shares Core Bond ETF Crosses $100 Million in Assets (PR Newswire)
WNS - WNS (Holdings) Limited - Stock Price Chart
TickerWNS [NYSE, RUT]
CompanyWNS (Holdings) Limited
CountryIndia
IndustryInformation Technology Services
Market Cap3.47BEPS (ttm)3.72
P/E20.08EPS this Y0.72%
Forward P/E14.40EPS next Y13.18%
PEG2.27EPS past 5Y10.49%
P/S2.64EPS next 5Y8.84%
P/B3.89EPS Q/Q329.19%
Dividend-Sales Q/Q-0.15%
Insider Own13.09%Inst Own84.86%
Insider Trans0.39%Inst Trans3.79%
Short Float5.83%EarningsApr 24/b
Analyst Recom2.00Target Price75.20
Avg Volume756.08K52W Range42.62 - 72.11
PBJA - PGIM S&P 500 Buffer 20 ETF - January - Stock Price Chart
TickerPBJA [CBOE]
CompanyPGIM S&P 500 Buffer 20 ETF - January
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Quant Strat
IndexSPDR S&P 500 ETF Trust
TagsU.S., options, buffer, upside-cap, fixed-period, large-cap, SP500
Sector/Theme Region
Dividend-Active/Passive
Total Holdings8AUM47.63M
Flows% 1M3.10%Flows% 3M-8.27%
Flows% YTD44.26%Flows% 1Y
Return% 1Y9.20%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume11.97K52W Range26.10 - 29.22
CGTX - Cognition Therapeutics Inc - Stock Price Chart
TickerCGTX [NASD]
CompanyCognition Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap35.89MEPS (ttm)-0.73
P/E-EPS this Y52.62%
Forward P/E-EPS next Y31.29%
PEG-EPS past 5Y-16.44%
P/S-EPS next 5Y32.88%
P/B2.92EPS Q/Q49.43%
Dividend-Sales Q/Q-
Insider Own19.35%Inst Own9.13%
Insider Trans0.32%Inst Trans10.61%
Short Float3.08%EarningsMay 07/b
Analyst Recom1.00Target Price3.25
Avg Volume1.41M52W Range0.22 - 2.54
Jul-01-25 07:30AM Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer's Disease Surpasses 50% Enrollment Target (GlobeNewswire)
Jun-25-25 07:30AM Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer's Disease and Dementia with Lewy Bodies (DLB) (GlobeNewswire)
Jun-03-25 07:30AM Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies (GlobeNewswire)
May-28-25 07:30AM Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies (GlobeNewswire) -5.76%
May-09-25 11:31AM Cognition announces outcomes from trial of zervimesine for geographic atrophy (Clinical Trials Arena) -8.76%
07:30AM Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health (GlobeNewswire)
May-08-25 07:30AM Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy (GlobeNewswire) -6.96%
May-07-25 07:30AM Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update (GlobeNewswire) -15.04%
Apr-01-25 07:30AM Cognition Therapeutics Presents Results at AD/PD 2025 Showing Impact of Zervimesine (CT1812) on Alzheimer's Disease Processes (GlobeNewswire) -6.82%
Mar-25-25 07:30AM Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer's Disease in Podium Presentation at AD/PD 2025 (GlobeNewswire) -6.23%
PTHS - Pelthos Therapeutics Inc - Stock Price Chart
TickerPTHS [AMEX]
CompanyPelthos Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap16.87MEPS (ttm)-17.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-18.68%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own9.89%
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price85.00
Avg Volume75.17K52W Range4.50 - 38.00
HERZ - Herzfeld Credit Income Fund Inc - Stock Price Chart
TickerHERZ [NASD]
CompanyHerzfeld Credit Income Fund Inc
CountryUSA
IndustryClosed-End Fund - Equity
Market Cap38.67MEPS (ttm)0.19
P/E12.95EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S42.96EPS next 5Y-
P/B0.80EPS Q/Q73.80%
Dividend18.86%Sales Q/Q23.90%
Insider Own52.98%Inst Own52.56%
Insider Trans3.68%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume43.83K52W Range2.15 - 2.80
12345671020